Episurf Medical AB (publ) (STO:EPIS.B)
Sweden · Delayed Price · Currency is SEK 0.0745
-0.0021 (-2.74%)
Sep 4, 2026, 5:29 PM CET
Episurf Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 12.2 | 7.1 | 50.5 | 57.9 | 155.3 | 237.9 |
Cash & Short-Term Investments | 12.2 | 7.1 | 50.5 | 57.9 | 155.3 | 237.9 |
Cash Growth | -62.58% | -85.94% | -12.78% | -62.72% | -34.72% | 53.48% |
Accounts Receivable | 7.3 | 4.9 | 2.2 | 1.4 | 1.9 | 1.6 |
Other Receivables | 1.5 | 2.5 | 3.7 | 1.8 | 2 | 2.4 |
Receivables | 8.8 | 7.4 | 5.9 | 3.2 | 3.9 | 4 |
Inventory | 2.7 | 3 | 3.2 | 3.7 | 1.9 | 1.9 |
Prepaid Expenses | - | 0.2 | 0.2 | 0.2 | - | 0.5 |
Other Current Assets | 17.9 | - | -0.1 | - | -0.1 | 0.1 |
Total Current Assets | 41.6 | 17.7 | 59.7 | 65 | 161 | 244.4 |
Property, Plant & Equipment | 5.3 | 5.1 | 2.8 | 5.6 | 6.7 | 3.3 |
Other Intangible Assets | 10.2 | 10.2 | 11.4 | 12.2 | 13.6 | 14.1 |
Long-Term Deferred Charges | 27.2 | 26.9 | 23.9 | 21.5 | 15.9 | 9 |
Other Long-Term Assets | 615.7 | -0.1 | - | - | - | -0.2 |
Total Assets | 722 | 59.8 | 97.8 | 104.3 | 197.2 | 270.6 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 55.2 | 3.4 | 3.2 | 6.1 | 4.4 | 5.9 |
Accrued Expenses | 10.2 | 3.5 | 7.6 | 7.6 | 7.2 | 5.9 |
Current Portion of Leases | 2.9 | 3 | 2.3 | 2.9 | 2.5 | 2.1 |
Other Current Liabilities | 45 | 0.5 | 0.8 | 0.8 | 0.6 | 0.3 |
Total Current Liabilities | 122.2 | 10.4 | 13.9 | 17.4 | 14.7 | 14.2 |
Long-Term Leases | 1.4 | 1.9 | - | 2.3 | 3.8 | 0.8 |
Other Long-Term Liabilities | 44 | - | 0.1 | 0.1 | 1 | 2.8 |
Total Liabilities | 167.6 | 12.3 | 14 | 19.8 | 19.5 | 17.8 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 28.1 | 16.6 | 6.5 | 80.2 | 80.1 | 80 |
Additional Paid-In Capital | 624.7 | 844.8 | 832.6 | 684.8 | 684.8 | 684.4 |
Retained Earnings | -98.7 | -813.7 | -755.2 | -680.2 | -587 | -511.3 |
Comprehensive Income & Other | 0.3 | -0.2 | -0.1 | -0.3 | -0.2 | -0.3 |
Shareholders' Equity | 554.4 | 47.5 | 83.8 | 84.5 | 177.7 | 252.8 |
Total Liabilities & Equity | 722 | 59.8 | 97.8 | 104.3 | 197.2 | 270.6 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4.3 | 4.9 | 2.3 | 5.2 | 6.3 | 2.9 |
Net Cash (Debt) | 7.9 | 2.2 | 48.2 | 52.7 | 149 | 235 |
Net Cash Growth | -69.62% | -95.44% | -8.54% | -64.63% | -36.60% | 55.53% |
Net Cash Per Share | 0.01 | 0.00 | 0.10 | 0.17 | 0.56 | 1.04 |
Filing Date Shares Outstanding | 2,810 | 1,660 | 651.48 | 267.07 | 266.91 | 266.54 |
Total Common Shares Outstanding | 2,810 | 1,660 | 651.48 | 267.07 | 266.91 | 266.54 |
Working Capital | -80.6 | 7.3 | 45.8 | 47.6 | 146.3 | 230.2 |
Book Value Per Share | 0.20 | 0.03 | 0.13 | 0.32 | 0.67 | 0.95 |
Tangible Book Value | 522.2 | 37.3 | 72.4 | 72.3 | 164.1 | 238.7 |
Tangible Book Value Per Share | 0.19 | 0.02 | 0.11 | 0.27 | 0.61 | 0.90 |
Machinery | - | - | - | 0.5 | 0.9 | 0.9 |